Login / Signup

Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment.

Thomas WilkeAnna-Katharina MeineckeBernhard SchaeferSandra BuchwaldDaniel ErikssonSabrina Müller
Published in: Cardiology research and practice (2019)
Patients primarily prefer a once-daily NOAC regimen. Individual preferences should be considered for the treatment of AF patients as this may result in improved treatment adherence and consequently better effectiveness and safety in routine clinical practice.
Keyphrases